Go Pro

Humacyte (HUMA) Short Interest Ratio & Short Volume

Humacyte logo
$0.66 -0.01 (-1.01%)
As of 03:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Humacyte Short Interest Overview

As of June 30, 2026, Humacyte (HUMA) had a short interest of 31.60 million shares sold short, representing 14.69% of the public float. This marks a -13.92% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.3, meaning it would take 1.3 days of the average trading volume of 8.35 million shares to cover all short positions.

Current Short Interest
31,597,133 shares
Previous Short Interest
36,706,340 shares
Change Vs. Previous Month
-13.92%
Dollar Volume Sold Short
$24.66 million
Short Interest Ratio
1.3 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
222,020,000 shares
Short Percent of Float
14.69%
Today's Trading Volume
2,638,659 shares
Average Trading Volume
8,352,685 shares
Today's Volume Vs. Average
32%
Short Selling Humacyte?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Humacyte and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

HUMA Short Interest Over Time

HUMA Days to Cover Over Time

HUMA Percentage of Float Shorted Over Time

Humacyte Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202631,597,133 shares $24.66 million -13.9%14.7%1.25 $0.78
6/15/202636,706,340 shares $39.28 million -8.6%17.1%4.1 $1.07
5/29/202640,140,620 shares $52.18 million -2.5%18.7%6.14 $1.30
5/15/202641,159,014 shares $38.28 million -7.9%19.1%5.19 $0.93
4/30/202644,703,015 shares $37.63 million -0.3%20.8%10.01 $0.84
4/15/202644,844,793 shares $33.01 million +6.2%20.8%9.4 $0.74
3/31/202642,223,438 shares $25.62 million +3.8%20.0%3.03 $0.61
3/13/202640,676,377 shares $47.18 million +6.6%22.9%10.36 $1.16
2/27/202638,162,880 shares $42.55 million -2.6%21.5%8.88 $1.12
2/13/202639,193,932 shares $39.59 million +0.9%18.2%5.22 $1.01
1/30/202638,837,697 shares $38.75 million +4.5%21.9%8.05 $1.00
1/15/202637,152,671 shares $40.87 million +2.2%20.9%7.58 $1.10
12/31/202536,355,101 shares $34.92 million +2.7%20.5%6.47 $0.96
12/15/202535,398,643 shares $41.77 million +2.2%19.9%9.26 $1.18
11/28/202534,652,802 shares $46.95 million +3.7%19.5%7.31 $1.36
11/14/202533,414,650 shares $41.10 million +3.6%18.8%6.29 $1.23
10/31/202532,241,263 shares $53.84 million +18.4%21.5%7.83 $1.67
10/15/202527,220,000 shares $48.18 million -5.5%17.6%4.9 $1.77
9/30/202528,790,000 shares $50.09 million -16.2%21.9%5.6 $1.74
9/15/202534,360,000 shares $52.57 million +2.3%26.1%7.8 $1.53
8/31/202533,600,000 shares $52.08 million -1.9%25.6%7.9 $1.55
8/15/202534,250,000 shares $64.39 million +7.5%26.1%7.4 $1.88
7/31/202531,870,000 shares $76.49 million -2.6%25.4%6.7 $2.40
7/15/202532,720,000 shares $74.60 million +7.0%26.1%8.1 $2.28
6/30/202530,580,000 shares $63.91 million +7.6%24.4%7.4 $2.09
6/15/202528,430,000 shares $67.38 million -10.6%22.7%5.8 $2.37
5/31/202531,800,000 shares $85.22 million +4.8%25.3%6.6 $2.68
5/15/202530,350,000 shares $57.36 million +20.7%24.1%6.8 $1.89
4/30/202525,150,000 shares $36.47 million -3.6%20.0%6.9 $1.45
4/15/202526,090,000 shares $40.18 million -3.9%20.8%7.5 $1.54
3/31/202527,140,000 shares $46.27 million +2.0%21.6%7.9 $1.71
3/15/202526,600,000 shares $80.86 million +4.4%25.5%6.8 $3.04
2/28/202525,480,000 shares $86.63 million +5.8%24.4%6.4 $3.40
2/15/202524,080,000 shares $94.15 million +0.2%23.1%6 $3.91
1/31/202524,040,000 shares $110.10 million -6.2%23.0%5.6 $4.58
1/15/202525,640,000 shares $117.43 million -13.4%24.6%5.7 $4.58
12/31/202429,620,000 shares $149.58 million +34.9%28.4%6.3 $5.05
12/15/202421,960,000 shares $90.04 million +8.0%21.0%5 $4.10
11/30/202420,330,000 shares $91.89 million +6.2%19.6%6.7 $4.52
11/15/202419,140,000 shares $92.54 million +11.0%18.5%6.3 $4.84
American’s Biggest Threat Is Here (Ad)

This feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, but that single shot started an avalanche of investigations, accusations, and conspiracy theories. That's what you just witnessed with the death of the Ayatolla Khamenei. Because the strikes proved how fragile things can get: billions could be lost. Seniors and the vulnerable put at risk.tc pixel

So to make it easy, Get the 2026 Retirement Survival Guide. Plain-English, step-by-step
10/31/202417,250,000 shares $87.11 million +3.4%17.6%5.8 $5.05
10/15/202416,680,000 shares $95.08 million +4.1%17.0%5.5 $5.70
9/30/202416,030,000 shares $87.20 million +14.4%16.4%5.1 $5.44
9/15/202414,010,000 shares $79.02 million +24.3%15.0%4.3 $5.64
8/31/202411,270,000 shares $68.18 million -1.2%12.1%3.4 $6.05
8/15/202411,410,000 shares $70.06 million -5.0%12.4%3.3 $6.14
7/31/202412,010,000 shares $113.61 million -17.7%13.1%3.5 $9.46
7/15/202414,600,000 shares $122.64 million +77.0%15.9%4.8 $8.40
6/30/20248,250,000 shares $39.60 million +58.7%9.0%3 $4.80
6/15/20245,200,000 shares $36.66 million +5.9%5.7%2.2 $7.05
5/31/20244,910,000 shares $36.73 million +17.2%5.4%2.4 $7.48
5/15/20244,190,000 shares $27.11 million -6.7%4.6%2.4 $6.47
4/30/20244,490,000 shares $17.60 million +14.0%5.0%3.2 $3.92
4/15/20243,940,000 shares $11.31 million -1.0%4.4%3 $2.87
3/31/20243,980,000 shares $12.38 million +5.3%4.6%4.1 $3.11
3/15/20243,780,000 shares $12.25 million -36.5%4.5%4.3 $3.24
2/29/20245,950,000 shares $25.88 million -9.3%7.0%7.6 $4.35
2/15/20246,560,000 shares $29.26 million +7.0%8.8%12 $4.46
1/31/20246,130,000 shares $20.35 million No Change8.2%13 $3.32
1/15/20246,130,000 shares $16.24 million +1.7%8.2%13.7 $2.65
12/31/20236,030,000 shares $17.13 million +8.5%8.1%13.2 $2.84
12/15/20235,560,000 shares $17.18 million -5.3%7.4%12.4 $3.09
11/30/20235,870,000 shares $15.56 million -3.6%7.8%10.9 $2.65
11/15/20236,090,000 shares $15.23 million +10.7%8.1%10.4 $2.50
10/31/20235,500,000 shares $11.66 million +7.8%7.4%7.7 $2.12
10/15/20235,100,000 shares $13.16 million -4.3%6.8%7.7 $2.58
9/30/20235,330,000 shares $15.62 million +1.5%7.1%8.3 $2.93
9/15/20235,250,000 shares $16.98 million +38.2%7.0%7.8 $3.24
8/31/20233,800,000 shares $14.55 million +19.1%5.7%5.5 $3.83
8/15/20233,190,000 shares $14.29 million +6.3%4.9%5.1 $4.48
7/31/20233,000,000 shares $9.84 million No Change4.7%6.3 $3.28
7/15/20233,000,000 shares $9.09 million +2.4%4.7%6.6 $3.03
6/30/20232,930,000 shares $8.38 million -1.7%4.5%6.7 $2.86
6/15/20232,980,000 shares $9.98 million -31.0%5.4%7.8 $3.35
5/31/20234,320,000 shares $14.82 million -21.7%7.6%15.7 $3.43
5/15/20235,520,000 shares $22.00 million +5.8%10.2%21 $3.99
4/30/20235,220,000 shares $16.91 million +0.2%9.7%21.9 $3.24
4/15/20235,210,000 shares $16.93 million -1.0%9.6%23.2 $3.25
3/31/20235,260,000 shares $16.25 million +3.3%9.7%22.6 $3.09
3/15/20235,090,000 shares $14.51 million +2.2%9.4%19 $2.85
2/28/20234,980,000 shares $15.24 million +3.5%9.8%14.7 $3.06
2/15/20234,810,000 shares $15.34 million +7.1%9.4%14.5 $3.19
1/31/20234,490,000 shares $11.81 million +3.0%8.8%13 $2.63
1/15/20234,360,000 shares $10.90 million -4.2%8.6%11.8 $2.50
12/30/20224,550,000 shares $9.60 million +1.6%8.9%11.7 $2.11
12/15/20224,480,000 shares $11.65 million +1.8%8.6%11.4 $2.60
11/30/20224,400,000 shares $13.73 million -4.4%8.5%12.7 $3.12
11/15/20224,600,000 shares $13.66 million -19.3%8.9%12.6 $2.97
10/31/20225,700,000 shares $19.61 million -13.6%11.0%13.8 $3.44
10/15/20226,600,000 shares $20.79 million -17.7%12.7%16.5 $3.15
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning (Ad)

The Department of Justice recently argued in court that cash may not be legally your property - raising concerns about government authority to freeze or seize private accounts. Greece raided pensions. Cyprus drained bank accounts. Poland seized retirement funds. Priority Gold has put together a free Wealth Defense Guide for Americans looking to move assets beyond potential government reach.tc pixel

Download your free Wealth Defense Guide and review your options today
9/30/20228,020,000 shares $26.15 million +2.0%15.5%19.8 $3.26
9/15/20227,860,000 shares $32.15 million -6.5%15.2%18.1 $4.09
8/31/20228,410,000 shares $30.70 million -5.9%16.7%20.1 $3.65
8/15/20228,940,000 shares $42.73 million +2.6%17.7%19.1 $4.78
7/31/20228,710,000 shares $30.31 million +5.5%17.3%19.7 $3.48
7/15/20228,260,000 shares $28.91 million +10.0%16.4%18.2 $3.50
6/30/20227,510,000 shares $24.11 million +1.6%14.9%16.4 $3.21
6/15/20227,390,000 shares $27.93 million -2.1%14.7%16.3 $3.78
5/31/20227,550,000 shares $41.00 million +21.2%15.0%18.2 $5.43
5/15/20226,230,000 shares $33.46 million +5.8%12.3%16.8 $5.37
4/30/20225,890,000 shares $41.70 million +3.9%11.7%17.4 $7.08
4/15/20225,670,000 shares $41.79 million +15.2%11.2%15.8 $7.37
3/31/20224,920,000 shares $34.74 million +11.6%9.8%12.1 $7.06
3/15/20224,410,000 shares $25.00 million +10.3%8.7%9.9 $5.67
2/28/20224,000,000 shares $24.12 million +0.5%7.9%7.6 $6.03
2/15/20223,980,000 shares $23.04 million +14.7%7.9%7.3 $5.79
1/31/20223,470,000 shares $18.67 million +17.2%7.1%6.1 $5.38
1/15/20222,960,000 shares $17.26 million +21.3%N/A0 $5.83
12/31/20212,440,000 shares $17.69 million No Change5.0%4.1 $7.25

HUMA Short Interest - Frequently Asked Questions

Short interest is the volume of Humacyte shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 31,597,133 shares of HUMA short. 14.69% of Humacyte's shares are currently sold short. Learn More on Humacyte's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUMA shares currently have a short interest ratio of 1.3. Learn More on Humacyte's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.69% of Humacyte's floating shares are currently sold short.

Humacyte saw a drop in short interest in June. As of June 30th, there was short interest totaling 31,597,133 shares, a drop of 13.9% from the previous total of 36,706,340 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

14.69% of Humacyte's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Humacyte: Forte Biosciences, Inc. (14.25%), Immix Biopharma, Inc. (20.78%), Ginkgo Bioworks Holdings, Inc. (9.05%), Altimmune, Inc. (24.89%), Contineum Therapeutics, Inc. (6.21%), Eikon Therapeutics, Inc. (8.55%), Arvinas, Inc. (7.14%), ProKidney Corp. (10.69%), Aquestive Therapeutics, Inc. (13.68%), Kyverna Therapeutics, Inc. (14.41%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling HUMA is an investing strategy that aims to generate trading profit from Humacyte as its price is falling. HUMA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Humacyte occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HUMA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUMA, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like HUMA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:HUMA) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners